Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2008; Volume 194, Supplement 665
The 59th National Congress of the Italian Physiological Society
9/17/2008-9/19/2008
Cagliari, Italy


ROLE OF ESTROGEN-LIKE COMPOUNDS ON CYTOKINE SECRETION IN AN IN VITRO MODEL OF HUMAN PLACENTA EXPLANTS
Abstract number: OC45

BECHI1 N, ROMAGNOLI1 R, SORDA1 G, IETTA1 F, PAULESU1 L

1Dept. Physiology, University of Siena, [email protected]

Aim: 

para-nonylphenol (p-NP) is a metabolite of alkylphenols widely used in chemicals and manufacturer industries. Previous studies have shown that p-NP plays an estrogen-like activity inducing trophoblast differentiation and apoptosis on first trimester human placental tissues. Since cytokines are important mediators of blastocyst implantation and placenta development, we analyzed the effect of p-NP on the release of MIF in in vitro cultures of chorionic villous explants from first trimester human placenta.

Methods: 

Chorionic villous explants were cultured and treated with p-NP (10-13, 10-11, 10-9 M) or only with vehicle (ethanol 0.1%) as control. Culture supernatants were collected after 24 hours and assayed by Luminex using specific BioSurce's Multiplex Bead Immunoassay for the following cytokines: GM-CSF, IL-2, IL-6, TNF-a, IFN-g, IL-4, IL-8, IL-1b, IL-5 and IL-10. The cytokine MIF was assayed by a colorimetric sandwich assay (ELISA).

Results: 

p-NP modulates cytokines secretion by inducing the release of GM-CSF, IL-6, IFN-g, IL-4, IL-8 and IL-1b at 10-9 M concentration while reducing release of MIF at all three concentrations. Level of IL-2, IL-5, IL-10 and TNF-a was remained under the detection limit both in treated and untreated control cultures.

Conclusion: 

An unbalanced cytokine network may result in implantation failure, pregnancy loss and/or other complications. Our findings on the effects of p-NP on cytokine release raised considerable concern about the implications of maternal exposure to endocrine disruptors during pregnancy.

To cite this abstract, please use the following information:
Acta Physiologica 2008; Volume 194, Supplement 665 :OC45

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE